Longo DL - Search Results

1

Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.

Wiltrout RH, Pilaro AM, Gruys ME, Talmadge JE, Longo DL, Ortaldo JR, Reynolds CW. Wiltrout RH, et al. Among authors: longo dl. J Immunol. 1989 Jul 1;143(1):372-8. J Immunol. 1989. PMID: 2732472

2

Effects of recombinant transforming growth factor-beta 1 on hematologic recovery after treatment of mice with 5-fluorouracil.

Jansen R, Damia G, Usui N, Keller J, Futami H, Goey H, Back TT, Longo DL, Ruscetti FW, Wiltrout RH. Jansen R, et al. Among authors: longo dl. J Immunol. 1991 Nov 15;147(10):3342-7. J Immunol. 1991. PMID: 1940339

3

Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.

Futami H, Jansen R, MacPhee MJ, Keller J, McCormick K, Longo DL, Oppenheim JJ, Ruscetti FW, Wiltrout RH. Futami H, et al. Among authors: longo dl. J Immunol. 1990 Dec 15;145(12):4121-30. J Immunol. 1990. PMID: 2258610

4

Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.

Hornung RL, Back TC, Zaharko DS, Urba WJ, Longo DL, Wiltrout RH. Hornung RL, et al. Among authors: longo dl. J Immunol. 1988 Nov 15;141(10):3671-9. J Immunol. 1988. PMID: 2460546

5

Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-beta 1.

Goey H, Keller JR, Back T, Longo DL, Ruscetti FW, Wiltrout RH. Goey H, et al. Among authors: longo dl. J Immunol. 1989 Aug 1;143(3):877-80. J Immunol. 1989. PMID: 2745976

6

Human natural lymphocyte effector cells: definition, analysis of activity, and clinical effectiveness.

Ortaldo JR, Longo DL. Ortaldo JR, et al. Among authors: longo dl. J Natl Cancer Inst. 1988 Sep 7;80(13):999-1010. doi: 10.1093/jnci/80.13.999. J Natl Cancer Inst. 1988. PMID: 3045334 Review.

7

Natural killer cells and bone marrow transplantation.

Murphy WJ, Reynolds CW, Tiberghien P, Longo DL. Murphy WJ, et al. Among authors: longo dl. J Natl Cancer Inst. 1993 Sep 15;85(18):1475-82. doi: 10.1093/jnci/85.18.1475. J Natl Cancer Inst. 1993. PMID: 8360930 Review.

8

Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.

Murphy WJ, Conlon KC, Sayers TJ, Wiltrout RH, Back TC, Ortaldo JR, Longo DL. Murphy WJ, et al. Among authors: longo dl. J Immunol. 1993 Apr 15;150(8 Pt 1):3634-42. J Immunol. 1993. PMID: 8468492

9

Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.

Raziuddin A, Longo DL, Mason L, Ortaldo JR, Murphy WJ. Raziuddin A, et al. Among authors: longo dl. Int Immunol. 1996 Dec;8(12):1833-9. doi: 10.1093/intimm/8.12.1833. Int Immunol. 1996. PMID: 8982767

10

Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.

Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ. Raziuddin A, et al. Among authors: longo dl. J Immunol. 1998 Jan 1;160(1):87-94. J Immunol. 1998. PMID: 9551959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

792 results

Search Page

Filters